top of page
Latest News
Pro PG receives S19A approval for - Ozempic 0.25mg & 0.5mg solution for injection in pre-filled pen
Dear Healthcare Professional, OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen AUST R: 308324 -...
Jun 27, 2022
76
![Pro PG receives S19A approval for OXYBUTYNIN CHLORIDE 5mg [100] Tabs (Novitium Pharma LLC, USA)](https://static.wixstatic.com/media/fa855b_5646d99c075b418291e5381abc7a4f1b~mv2.jpeg/v1/fill/w_569,h_313,fp_0.50_0.50,lg_1,q_30,blur_30,enc_avif,quality_auto/fa855b_5646d99c075b418291e5381abc7a4f1b~mv2.jpeg)
![Pro PG receives S19A approval for OXYBUTYNIN CHLORIDE 5mg [100] Tabs (Novitium Pharma LLC, USA)](https://static.wixstatic.com/media/fa855b_5646d99c075b418291e5381abc7a4f1b~mv2.jpeg/v1/fill/w_569,h_313,fp_0.50_0.50,lg_1,q_90,enc_avif,quality_auto/fa855b_5646d99c075b418291e5381abc7a4f1b~mv2.jpeg)
Pro PG receives S19A approval for OXYBUTYNIN CHLORIDE 5mg [100] Tabs (Novitium Pharma LLC, USA)
Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered DITROPAN oxybutynin hydrochloride 5mg tablet...
Jun 23, 2022
56
bottom of page